Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-21
    E.g., 2018-10-21

Articles

Pages

1402 items
12:32 PM, Oct 19, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Reports say Innovent seeking $422M IPO in Hong Kong

Innovent Biologics Inc. (Suzhou, China) did not respond to inquiries regarding reports that the company is seeking to raise $422 million in an IPO on the Hong Kong stock exchange, which would value the company...
4:07 PM, Oct 11, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Gene therapy developer Orchard proposes IPO

Orchard Therapeutics Ltd. (London, U.K.) proposed to raise up to $172.5 million in an IPO on NASDAQ. J.P. Morgan, Goldman Sachs, Cowen and Wedbush PacGrow are underwriters. Orchard is developing autologous ex vivo lentiviral gene therapies...
1:14 PM, Oct 05, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

New IPO filings include NGM, Arog, Gamida

Three biotechs filed late Sept. 28 to go public on NASDAQ, adding new companies to a 2018 class of IPOs that could surpass 2015's record for funds raised. The group includes NGM Biopharmaceuticals Inc. (South...
12:26 PM, Sep 28, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Shanghai Henlius to move forward with Hong Kong listing

Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196) said on Sept. 27 its board approved a resolution to list Shanghai Henlius Biotech Inc. (Shanghai, China) on the Hong Kong stock exchange. Shanghai Henlius, a JV between Fosun...
11:42 AM, Sep 28, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

PhaseBio files for $86.3M NASDAQ IPO

PhaseBio Pharmaceuticals Inc. (Malvern, Pa.) proposed on Sept. 21 to raise $86.3 million in an IPO on NASDAQ underwritten by Citigroup, Cowen, Stifel and Needham. On Sept. 7, PhaseBio raised $34 million in a series...
11:03 AM, Sep 28, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Gene therapy play LogicBio proposes IPO

Gene therapy company LogicBio Therapeutics Inc. (Cambridge, Mass.) proposed to raise up to $86 million in an IPO on NASDAQ underwritten by Jefferies, Barclays, William Blair and Chardan. LogicBio is developing gene therapies to address rare...
9:33 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Ex-Kite execs prep quick IPO for CAR T play Allogene

Cell therapy start-up Allogene Therapeutics Inc. (South San Francisco, Calif.) filed to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, Cowen and Jefferies. Launched in April with...
9:32 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Equillium proposes $86.3M IPO

Autoimmune and inflammatory disease company Equillium Inc. (La Jolla, Calif.) proposed to raise up to $86.3 million on Sept. 17 in an IPO on NASDAQ underwritten by Jefferies, Leerink and Stifel. The company has U.S. and...
9:31 AM, Sep 21, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

WuXi AppTec queues up for Hong Kong listing

Less than five months after its IPO in Shanghai, WuXi AppTec Co. Ltd. (Shanghai:603259) proposed Sept. 18 to list on the Hong Kong stock exchange in an offering underwritten by Morgan Stanley Asia, Huatai Financial...
3:44 PM, Sep 13, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Kodiak files for IPO

Ophthalmic company Kodiak Sciences Inc. (Palo Alto, Calif.) filed to raise $100 million in an IPO on NASDAQ underwritten by Morgan Stanley, BofA Merrill Lynch, Barclays and Chardan. Using its antibody biopolymer conjugate (ABC) platform, Kodiak...

Pages